SCHEMBL5126489

SCHEMBL5126489

CCOC1Oc2c(c(=O)oc3c(OC)cccc23)C1c1c(O)c2cccc(OC)c2oc1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 9/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ANTXR2 P58335 1/20 0.36
NQO1 P15559 1/20 0.35
HPGD P15428 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA3 P07451 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125212 0.89 MAOA (0.40) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL5110816 0.87 ESR2 (0.34) MAOAALDH1A1ANTXR2NQO1MCL1
SCHEMBL5125504 0.80 CNR2 (0.32) KDM4ENQO1MCL1
SCHEMBL5114210 0.79 ALDH1A1 (0.47) ALDH1A1KDM4ELMNANQO1HPGD
SCHEMBL5112371 0.77 ESR2 (0.36) MAOAANTXR2NQO1MCL1PRKDC
SCHEMBL5115962 0.75 NQO1 (0.52) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL5114980 0.75 NQO1 (0.52) MAOAALDH1A1KDM4ENPC1RAB9A
SCHEMBL5114216 0.74 CNR2 (0.32) LMNANQO1HPGDCYP3A4CA1
SCHEMBL5125494 0.74 NQO1 (0.47) ALDH1A1NQO1MAPTMEN1KMT2A
SCHEMBL5119698 0.73 PRNP (0.40) MAOAALDH1A1KDM4ENQO1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S MAOA 327/4885ALDH1A1 486/4885KDM4E 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.